As of May 2023, there was no news or official announcement that Shuanglu Pharmaceutical was about to change into a central enterprise. You can pay attention to authoritative news media or official announcements to get the latest information.
Shuanglu Pharmaceutical Co., Ltd. is a pharmaceutical enterprise specializing in the research, development, production and management of genetic engineering drugs. Its predecessor was Beijing Bailuyuan Biotechnology Co., Ltd., which was established in February 1994. 1In July, 1998, the company changed its name to Beijing Shuanglu Pharmaceutical Co., Ltd., was restructured into a joint stock limited company in August, 2000, and was listed on Shenzhen Stock Exchange in September, 2004.